Contemporary OB/GYN week in review: vasomotor symptoms, OTC contraceptive, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: vasomotor symptoms, OTC contraceptive, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, March 18 - Friday, March 22 2024), and click each link to read and watch anything you may have missed.
1.) Nighttime vasomotor symptoms linked to Alzheimer's risk
Delve into the connection between nighttime vasomotor symptoms and Alzheimer's disease risk in women, shedding light on potential modifiable factors impacting cognitive health.
Click here for the full article.
2.) First OTC contraceptive now available
Online orders began this week for the first over the over-the-counter contraceptive, Opill (norgestrel; Perrigo).
Click here for the full article.
3.) Study unveils maternal mortality tracking trends
Delve into the implications of a study investigating maternal mortality tracking methods in the United States, as OB Hospitalist Group's Chief Medical Officer, Mark Simon, MD, highlights critical factors often overlooked and emphasizes collaborative care for preventing deaths.
Click here for the full article.
4.) Global fertility rates plummet: Implications for future populations
Global fertility rates plummet: Implications for future populations | Image Credit: © annaperevozkina - © annaperevozkina - stock.adobe.com.
Recent research reveals a stark decline in global fertility rates, with 76% of countries projected to fall below the population-sustaining threshold by 2050, prompting urgent calls for policy interventions to address demographic shifts.
Click here for the full article.
5.) Exploring racial disparities in IVF outcomes
A recent study delves into how neighborhood socioeconomic factors affect miscarriage and live birth rates post- in vitro fertilization across diverse racial populations, not finding a correlation with neighborhood-level socioeconomic factors.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
